Enzymotec (NASDAQ: ENZY) and UFP Technologies (NASDAQ:UFPT) are both small-cap basic materials companies, but which is the superior business? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, dividends, earnings and institutional ownership.

Risk and Volatility

Enzymotec has a beta of 1.22, meaning that its share price is 22% more volatile than the S&P 500. Comparatively, UFP Technologies has a beta of 0.13, meaning that its share price is 87% less volatile than the S&P 500.


This table compares Enzymotec and UFP Technologies’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Enzymotec 2.32% 1.24% 0.84%
UFP Technologies 5.43% 6.83% 6.03%

Earnings and Valuation

This table compares Enzymotec and UFP Technologies’ gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Enzymotec $47.70 million 5.82 -$2.92 million ($0.27) -43.89
UFP Technologies $146.13 million 1.44 $7.97 million $1.09 26.61

UFP Technologies has higher revenue and earnings than Enzymotec. Enzymotec is trading at a lower price-to-earnings ratio than UFP Technologies, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of recent recommendations and price targets for Enzymotec and UFP Technologies, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Enzymotec 0 2 0 0 2.00
UFP Technologies 0 0 0 0 N/A

Enzymotec currently has a consensus target price of $11.75, suggesting a potential downside of 0.84%. Given Enzymotec’s higher probable upside, equities research analysts plainly believe Enzymotec is more favorable than UFP Technologies.

Institutional & Insider Ownership

15.7% of Enzymotec shares are held by institutional investors. Comparatively, 69.2% of UFP Technologies shares are held by institutional investors. 13.3% of UFP Technologies shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.


UFP Technologies beats Enzymotec on 9 of the 12 factors compared between the two stocks.

About Enzymotec

Enzymotec Ltd. is a nutritional ingredients and medical foods company. The Company’s technologies, research expertise and clinical validation process enables it to develop solutions across a range of products. The Company operates in two segments: Nutrition segment and VAYA Pharma segment. Both of the Company’s segments offer a range of products that leverage its lipid-related offerings. Its product suite addresses the entire human life-cycle, from infancy to old age, and comprises ingredients in products ranging from infant formula to nutritional supplements, as well as branded medical foods, sold only under a doctor’s supervision. It markets its product portfolio to established global consumer companies and physicians and target large and growing consumer health and wellness markets. The Company’s clinically-validated products include bio-functional lipid-based compounds designed to address dietary needs, medical disorders and common diseases.

About UFP Technologies

UFP Technologies, Inc. is a designer and custom converter of foams, plastics, composites and natural fiber materials. The Company is engaged in providing solutions to customers primarily within the medical, automotive, consumer, electronics, industrial, and aerospace and defense markets. It converts these materials using laminating, molding, and fabricating manufacturing technologies. The Company’s raw materials consist of polyethylene and polyurethane foams, sheet plastics, pulp fiber, cross-linked polyethylene and reticulated polyurethane foams, fabric and foam laminates, and natural fiber materials. The Company converts these materials to provide customers various solutions, including automotive interior trim, medical device components, disposable wound care components, military uniform and gear components, athletic padding, air filtration, high-temperature insulation, abrasive nail files and other beauty aids, and cushion packaging for their products.

Receive News & Ratings for Enzymotec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enzymotec and related companies with MarketBeat.com's FREE daily email newsletter.